comparemela.com

Latest Breaking News On - Affinity care - Page 4 : comparemela.com

LumiraDx COVID-19 & Flu A/B Rapid Antigen Test Achieves CE Marking

/PRNewswire/ LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced its SARS-CoV-2 & Flu A/B Antigen Test has.

United kingdomRon zwanzigerColleen mcmillenMatthew fayExchange commissionChief executive officerEuropean regionPrimary careClinical chief executiveAffinity careWillows medical practiceLumiradx platformSecurities litigation reform actProxy statement

LumiraDx COVID-19 & Flu A/B Rapid Antigen Test Achieves CE Marking

- Rapid microfluidic immunofluorescence assay for use with the LumiraDx Platform intended for the simultaneous detection and differentiation of SARS-CoV-2,.

United kingdomRon zwanzigerColleen mcmillenMatthew fayExchange commissionChief executive officerEuropean regionPrimary careClinical chief executiveAffinity careWillows medical practiceLumiradx platformSecurities litigation reform actProxy statement

LumiraDx COVID-19 & Flu A/B Rapid Antigen Test Achieves CE Marking

- Rapid microfluidic immunofluorescence assay for use with the LumiraDx Platform intended for the simultaneous detection and differentiation of SARS-CoV-2, influenza A, and influenza B viral

United kingdomCity ofRon zwanzigerColleen mcmillenMatthew fayExchange commissionLumiradx platformFor influenzaChief executive officerEuropean regionPrimary careClinical chief executiveAffinity careWillows medical practiceSecurities litigation reform actProxy statement

LumiraDx COVID-19 & Flu A/B Rapid Antigen Test Achieves CE Marking

LONDON, Dec. 23, 2021 /PRNewswire/ LumiraDx , a next-generation point of care diagnostics company, today announced its SARS-CoV-2 & Flu A/B Antigen Test has achieved CE. | December 23, 2021

United kingdomCity ofRon zwanzigerColleen mcmillenMatthew fayExchange commissionAntigen testLumiradx platformFor influenzaChief executive officerEuropean regionPrimary careClinical chief executiveAffinity careWillows medical practiceSecurities litigation reform act

Medalogix Muse Empowers Continuum Care Hospice and Affinity Care Hospice with Machine Learning Tool

/PRNewswire/ Continuum Care Hospice and Affinity Care Hospice, a New York based hospice and palliative care provider operating in seven states, has.

New yorkUnited statesMedalogix museElliott woodLinkedin medalogixContinuum care hospiceAffinity care hospiceSamuel sternAffinity care

vimarsana © 2020. All Rights Reserved.